FDA Inspection
Amol Pharmaceuticals Private Ltd.Amol Pharmaceuticals Private Ltd. – FDA Inspection, Sep 13, 2019
Record Details
This FDA Inspection record concerns Amol Pharmaceuticals Private Ltd., with an inspection on September 13, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5d48b063-bb1c-479e-a4bc-b8cdb4aa24ee
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1101798
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Amol Pharmaceuticals Private Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2025 | Not classified | Office of Inspections and Investigations | |
| February 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2017 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| May 15, 2012 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Amol Pharmaceuticals Private Ltd.
- FDA Inspection 1265781 - 2025-03-28
- FDA Inspection 1041368 - 2018-02-16
- FDA Inspection 1037842 - 2017-12-05
- FDA Inspection 783531 - 2012-05-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.